Exhibit 99.1
Craig Colosso Relationship Management |
| |
American Stock Transfer & Trust Company, LLC |
|
March 10, 2022
Alberta Securities Commission |
British Columbia Securities Commission |
Ontario Securities Commission |
RE: Xenon Pharmaceuticals Inc.
Pursuant to a request from the above-mentioned reporting issuer, we wish to advise you of the following information in connection with its Annual Meeting of Shareholders:
Date of meeting: | June 1, 2022 |
Record date for notice: | April 5, 2022 |
Record date for voting: | April 5, 2022 |
Beneficial ownership determination date: | April 5, 2022 |
Securities entitled to notice: | Common Shares and Series 1 Preferred Shares |
Securities entitled to vote: | Common Shares and Series 1 Preferred Shares |
Issuer mailing directly to non objecting beneficial owners: | No |
Issuer will pay for objecting beneficial owner material distribution: | Yes |
Issuer using notice-and-access for registered investors: | No |
Issuer using notice-and-access for non-registered investors: | No |
Notice-and-access stratification criteria: | N/A |
Yours very truly,
/s/ Craig Colosso
Craig Colosso
Relationship Manager
American Stock Transfer & Trust Company, LLC